Sanofi Pasteur (SNY) Approved in Mexico to Market Dengvaxia for Dengue Prevention

December 9, 2015 10:33 AM EST Send to a Friend
Sanofi Pasteur, the vaccines division of Sanofi (NYSE: SNY), announced that the Mexican authorities have granted marketing authorization to Dengvaxia® ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login